896 related articles for article (PubMed ID: 30197484)
21. LR-M Observations on Contrast-Enhanced Ultrasound: Detection of Hepatocellular Carcinoma Using Additional Features in Comparison With Current LI-RADS Criteria.
Xian MF; Huang Y; Xie WX; Pan KM; Zeng D; Huang H; Li MD; Xie XY; Kuang M; Lu MD; Chen LD; Wang W
AJR Am J Roentgenol; 2022 Jul; 219(1):76-85. PubMed ID: 34910538
[No Abstract] [Full Text] [Related]
22. Diagnostic performance of magnetic resonance imaging and contrast-enhanced ultrasound in differentiating intrahepatic cholangiocarcinoma from hepatocellular carcinoma: a meta-analysis.
Wu Y; Xia C; Chen J; Qin Q; Ye Z; Song B
Abdom Radiol (NY); 2024 Jan; 49(1):34-48. PubMed ID: 37823913
[TBL] [Abstract][Full Text] [Related]
23. Intratumoral artery on contrast-enhanced computed tomography imaging: differentiating intrahepatic cholangiocarcinoma from poorly differentiated hepatocellular carcinoma.
Tsunematsu S; Chuma M; Kamiyama T; Miyamoto N; Yabusaki S; Hatanaka K; Mitsuhashi T; Kamachi H; Yokoo H; Kakisaka T; Tsuruga Y; Orimo T; Wakayama K; Ito J; Sato F; Terashita K; Nakai M; Tsukuda Y; Sho T; Suda G; Morikawa K; Natsuizaka M; Nakanishi M; Ogawa K; Taketomi A; Matsuno Y; Sakamoto N
Abdom Imaging; 2015 Aug; 40(6):1492-9. PubMed ID: 25579172
[TBL] [Abstract][Full Text] [Related]
24. Differentiation between hepatocellular carcinoma and intrahepatic cholangiocarcinoma using contrast-enhanced ultrasound: A systematic review and meta-analysis.
Chen Y; Zhu Y; Chen K; Wang H; Zhang W; Bao J; Wang W
Clin Hemorheol Microcirc; 2021; 79(2):293-309. PubMed ID: 33935070
[TBL] [Abstract][Full Text] [Related]
25. Potential diagnostic performance of contrast-enhanced ultrasound and tumor markers in differentiating combined hepatocellular-cholangiocarcinoma from hepatocellular carcinoma and cholangiocarcinoma.
Huang XW; Huang Y; Chen LD; Wang Z; Yang Z; Liu JY; Xie XY; Lu MD; Shen SL; Wang W
J Med Ultrason (2001); 2018 Apr; 45(2):231-241. PubMed ID: 29052791
[TBL] [Abstract][Full Text] [Related]
26. Dynamic contrast-enhanced ultrasound (DCE-US) for the characterization of hepatocellular carcinoma and cholangiocellular carcinoma.
Wildner D; Pfeifer L; Goertz RS; Bernatik T; Sturm J; Neurath MF; Strobel D
Ultraschall Med; 2014 Dec; 35(6):522-7. PubMed ID: 25202903
[TBL] [Abstract][Full Text] [Related]
27. Multiparametric Dynamic Ultrasound Approach for Differential Diagnosis of Primary Liver Tumors.
Ainora ME; Cerrito L; Liguori A; Mignini I; De Luca A; Galasso L; Garcovich M; Riccardi L; Ponziani F; Santopaolo F; Pompili M; Gasbarrini A; Zocco MA
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37239893
[TBL] [Abstract][Full Text] [Related]
28. Imaging features of hepatocellular carcinoma compared to intrahepatic cholangiocarcinoma and combined tumor on MRI using liver imaging and data system (LI-RADS) version 2014.
Horvat N; Nikolovski I; Long N; Gerst S; Zheng J; Pak LM; Simpson A; Zheng J; Capanu M; Jarnagin WR; Mannelli L; Do RKG
Abdom Radiol (NY); 2018 Jan; 43(1):169-178. PubMed ID: 28765978
[TBL] [Abstract][Full Text] [Related]
29. Diagnostic value of CEUS LI-RADS and serum tumor markers for combined hepatocellular-cholangiocarcinoma.
Wen R; Lin P; Wu Y; Yin H; Huang W; Guo D; Peng Y; Liu D; He Y; Yang H
Eur J Radiol; 2022 Sep; 154():110415. PubMed ID: 35738166
[TBL] [Abstract][Full Text] [Related]
30. Characteristics of contrast-enhanced ultrasound in distinguishing small (≤3 cm) hepatocellular carcinoma from intrahepatic cholangiocarcinoma.
Shin SK; Choi DJ; Kim JH; Kim YS; Kwon OS
Medicine (Baltimore); 2018 Oct; 97(41):e12781. PubMed ID: 30313099
[TBL] [Abstract][Full Text] [Related]
31. Factors Affecting the Enhancement Patterns of Intrahepatic Cholangiocarcinoma (ICC) on Contrast-Enhanced Ultrasound (CEUS) and their Pathological Correlations in Patients with a Single Lesion.
Yuan MX; Li R; Zhang XH; Tang CL; Guo YL; Guo DY; Luo MK
Ultraschall Med; 2016 Dec; 37(6):609-618. PubMed ID: 25919414
[No Abstract] [Full Text] [Related]
32. Patterns of appearance and risk of misdiagnosis of intrahepatic cholangiocarcinoma in cirrhosis at contrast enhanced ultrasound.
Galassi M; Iavarone M; Rossi S; Bota S; Vavassori S; Rosa L; Leoni S; Venerandi L; Marinelli S; Sangiovanni A; Veronese L; Fraquelli M; Granito A; Golfieri R; Colombo M; Bolondi L; Piscaglia F
Liver Int; 2013 May; 33(5):771-9. PubMed ID: 23445369
[TBL] [Abstract][Full Text] [Related]
33. Interobserver and intermodality agreement of standardized algorithms for non-invasive diagnosis of hepatocellular carcinoma in high-risk patients: CEUS-LI-RADS versus MRI-LI-RADS.
Schellhaas B; Hammon M; Strobel D; Pfeifer L; Kielisch C; Goertz RS; Cavallaro A; Janka R; Neurath MF; Uder M; Seuss H
Eur Radiol; 2018 Oct; 28(10):4254-4264. PubMed ID: 29675659
[TBL] [Abstract][Full Text] [Related]
34. Differentiation of mass-forming intrahepatic cholangiocarcinoma from poorly differentiated hepatocellular carcinoma: based on the multivariate analysis of contrast-enhanced computed tomography findings.
Zhao YJ; Chen WX; Wu DS; Zhang WY; Zheng LR
Abdom Radiol (NY); 2016 May; 41(5):978-89. PubMed ID: 27193795
[TBL] [Abstract][Full Text] [Related]
35. Diagnostic efficacy of contrast-enhanced ultrasound versus MRI Liver Imaging Reporting and Data System (LI-RADS) for categorising hepatic observations in patients at risk of hepatocellular carcinoma.
Li S; Zhou L; Chen R; Chen Y; Niu Z; Qian L; Fang Y; Xu L; Xu H; Zhang L
Clin Radiol; 2021 Feb; 76(2):161.e1-161.e10. PubMed ID: 33198943
[TBL] [Abstract][Full Text] [Related]
36. MR versus CEUS LI-RADS for Distinguishing Hepatocellular Carcinoma from other Hepatic Malignancies in High-Risk Patients.
Huang Z; Zhou P; Li S; Li K
Ultrasound Med Biol; 2021 May; 47(5):1244-1252. PubMed ID: 33610338
[TBL] [Abstract][Full Text] [Related]
37. Imaging features of combined hepatocellular-cholangiocarcinoma on contrast-enhanced ultrasound: correlation with clinicopathological findings.
Ye J; Xie X; Lin Y; Liu B; Wang W; Huang X; Huang G
Clin Radiol; 2018 Mar; 73(3):237-243. PubMed ID: 29122222
[TBL] [Abstract][Full Text] [Related]
38. Combined Hepatocellular Cholangiocarcinoma (Biphenotypic) Tumors: Potential Role of Contrast-Enhanced Ultrasound in Diagnosis.
Li F; Han J; Han F; Wang JW; Luo RZ; Li AH; Zhou JH
AJR Am J Roentgenol; 2017 Oct; 209(4):767-774. PubMed ID: 28777653
[TBL] [Abstract][Full Text] [Related]
39. Implications of ultrasound-based deep learning model for preoperatively differentiating combined hepatocellular-cholangiocarcinoma from hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
Chen J; Zhang W; Bao J; Wang K; Zhao Q; Zhu Y; Chen Y
Abdom Radiol (NY); 2024 Jan; 49(1):93-102. PubMed ID: 37999743
[TBL] [Abstract][Full Text] [Related]
40. Contrast-enhanced ultrasound (CEUS) in the diagnostic algorithm of hepatocellular and cholangiocellular carcinoma, comments on the AASLD guidelines.
Dietrich CF; Cui XW; Boozari B; Hocke M; Ignee A
Ultraschall Med; 2012 Jul; 33 Suppl 1():S57-66. PubMed ID: 22723030
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]